Posted on 1/7/21
CARISMA Therapeutics Completes $47 Million Series B Funding
CARISMA Therapeutics Inc., a biopharmaceutical company focused on discovering and developing innovative immunotherapies, announced today that it has completed its Series B equity financing providing for . . .
Posted on 1/7/21
Biohaven Acquires Kleo Pharmaceuticals
Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) today announced the acquisition of the remaining 58% interest of Kleo Pharmaceuticals, Inc. that it did not previously own . . .
Posted on 1/7/21
Werewolf Therapeutics Completes $72 Million Series B Financing
Werewolf Therapeutics, Inc., an oncology biotherapeutics company advancing a pipeline of next-generation, transformative cancer treatments, today announced the completion of its $72 million Series B financing.
Posted on 1/7/21
Alira Health Acquires Chamow and Associates
Alira Health, a leading international healthcare and life sciences advisory firm, announced it has acquired Chamow and Associates, a California-based integrated CMC
Posted on 1/7/21
Kennedy Krieger Institute Appoints John Campo VP of Psychiatric Services
Kennedy Krieger Institute has announced the appointment of Dr. John Campo as Vice President of Psychiatric Services
Posted on 1/7/21
Micron Medical Issues a Letter to Shareholders
BOCA RATON, Fla., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Micron Medical, a privately-held medical device company engaged in the development, manufacture and early stage commercialization of . . .
Posted on 1/7/21
Onconova Therapeutics Announces $8.7 Million Public Offering
NEWTOWN, Pa., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a biopharmaceutical company focused on discovering and developing novel products to treat cancer, . . .
Posted on 1/7/21
Aquestive Therapeutics Provides Business Update
WARREN, N.J., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address patients’ . . .
Posted on 1/7/21
Pacira Reports Record Revenue for 2020 of $429.6 Million
PARSIPPANY, N.J., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the leading provider of innovative non-opioid pain management options, today reported preliminary unaudited . . .
Posted on 1/7/21
Maryland Medical Device Companies Develop Life Saving Solutions To Complex Challenges
From providing better outcomes for kidney failure patients to improving wound treatment and addressing blood shortages, life-saving innovation is at the heart of medical device companies . . .
Posted on 1/7/21
Dane D. Hallberg Launches MASORI Therapeutics
Veteran biopharma industry executive Dane D. Hallberg today announced the formation of a new company, MASORI Therapeutics, to help firms create innovative market solutions and achieve . . .
Posted on 1/7/21
La.-Based Health Care Company Buys Two Va. Practices
Shreveport, Louisiana-based Seaside Healthcare LLC announced Tuesday it has acquired two Virginia mental health care practices: Chesterfield-based Simple Intervention and Hopewell-based Second Chances Comprehensive Services LLC.Financial . . .
Posted on 1/7/21
Estes Express Lines, Family Commit $2M to Children’s Hospital of Richmond at VCU
The Children’s Hospital Foundation announced Wednesday that Richmond-based Estes Express Lines donated $150,000 — with another $1.85 million committed from the Estes family — to support . . .
Posted on 1/7/21
LifeMine Therapeutics Raises $50 Million Series B
LifeMine Therapeutics Inc., a biopharmaceutical company reinventing drug discovery by mining fungal biodiversity to develop mechanistically and structurally novel therapeutics, today announced a $50 million
Posted on 1/7/21
Scorpion Therapeutics Raises $162M In Series B
Scorpion Therapeutics, Inc., a next-generation precision oncology company, today announced the closing of an oversubscribed Series B financing, which raised $162 million.
Posted on 1/7/21
Is Pfizer Stock a Buy?
Steve Jobs once told biographer Walter Isaacson, "Deciding what not to do is as important as deciding what to do." Pfizer (NYSE:PFE) has taken that message . . .
Posted on 1/7/21
Berkshire Hathaway Q4 2020 Earnings And Book Value Estimates
SummaryBerkshire lagged the S&P 500 significantly in 2020, gaining 2.4% vs. the S&P 500's total return of 18.4%.Berkshire's equity book gained 13.3% in Q4 to $259.6 . . .
Posted on 1/7/21
bluebird bio Inc., Undervalued Acquisition Candidate
SummaryI estimate the fair value for BLUE between $5-7 billion based on similar acquisitions.2021 could be an inflection point with the anticipated approval of the company's . . .
Posted on 1/7/21
Moderna Coronavirus Vaccine Approved in Europe
Less than a month after winning emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its coronavirus vaccine, Moderna (NASDAQ:MRNA) has scored . . .
Posted on 1/7/21
Generation Bio Prices of Public Offering
CAMBRIDGE, Mass., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of gene therapy, today . . .
Posted on 1/6/21
Chiasma Provides Corporate Update
NEEDHAM, Mass., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), a commercial-stage biopharmaceutical company utilizing its delivery platform technology to develop and commercialize oral . . .
Posted on 1/6/21
REGENXBIO Proposes Public Offering Of Common Stock
REGENXBIO Inc. (Nasdaq:RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV® Technology Platform, . . .
Posted on 1/6/21
Maryland’s Coronavirus Hospitalizations Reach Highest Point of Pandemic With 1,862 Patients
There are now 1,862 Marylanders hospitalized with coronavirus, marking the largest number of hospitalizations in the state since the beginning of the pandemic.The state’s previous record . . .
Posted on 1/6/21
AdaptHealth Corp. Public Offering of Class A Common Stock
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO), a leading provider of home medical equipment, supplies and related services in the United States, announced today the pricing . . .
Posted on 1/6/21
Aileron Therapeutics Announces $35.9 Million Registered Direct Offering
WATERTOWN, Mass., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Aileron Therapeutics, Inc. (Nasdaq: ALRN), today announced that it has entered into definitive agreements with fundamental healthcare investors . . .
